Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 1
1977 1
1978 1
1979 1
1980 1
1981 5
1982 6
1983 3
1984 2
1985 3
1986 5
1987 3
1988 2
1989 3
1990 3
1991 2
1992 4
1994 1
1995 2
1996 1
1997 2
1998 5
1999 5
2000 5
2001 1
2002 6
2003 2
2004 10
2005 17
2006 10
2007 14
2008 13
2009 12
2010 13
2011 13
2012 11
2013 12
2014 6
2015 3
2016 18
2017 10
2018 6
2019 12
2020 14
2021 14
2022 9
2023 23
2024 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

286 results

Results by year

Filters applied: . Clear all
Page 1
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D; SONAR Committees and Investigators. Heerspink HJL, et al. Lancet. 2019 May 11;393(10184):1937-1947. doi: 10.1016/S0140-6736(19)30772-X. Epub 2019 Apr 14. Lancet. 2019. PMID: 30995972 Clinical Trial.
Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial.
Ueki K, Sasako T, Okazaki Y, Kato M, Okahata S, Katsuyama H, Haraguchi M, Morita A, Ohashi K, Hara K, Morise A, Izumi K, Ishizuka N, Ohashi Y, Noda M, Kadowaki T; J-DOIT3 Study Group. Ueki K, et al. Lancet Diabetes Endocrinol. 2017 Dec;5(12):951-964. doi: 10.1016/S2213-8587(17)30327-3. Epub 2017 Oct 24. Lancet Diabetes Endocrinol. 2017. PMID: 29079252 Clinical Trial.
Clinical impact of sarcopenia and dynapenia on diabetes.
Mori H, Kuroda A, Matsuhisa M. Mori H, et al. Among authors: matsuhisa m. Diabetol Int. 2019 Jun 19;10(3):183-187. doi: 10.1007/s13340-019-00400-1. eCollection 2019 Jul. Diabetol Int. 2019. PMID: 31275784 Free PMC article.
Role of MafA in pancreatic beta-cells.
Kaneto H, Matsuoka TA, Kawashima S, Yamamoto K, Kato K, Miyatsuka T, Katakami N, Matsuhisa M. Kaneto H, et al. Among authors: matsuhisa m. Adv Drug Deliv Rev. 2009 Jul 2;61(7-8):489-96. doi: 10.1016/j.addr.2008.12.015. Epub 2009 Apr 22. Adv Drug Deliv Rev. 2009. PMID: 19393272 Review.
New risk factors of severe hypoglycemia.
Matsuhisa M, Kuroda A. Matsuhisa M, et al. J Diabetes Investig. 2019 Mar;10(2):219-220. doi: 10.1111/jdi.12925. Epub 2018 Oct 13. J Diabetes Investig. 2019. PMID: 30175462 Free PMC article. No abstract available.
PDX-1 functions as a master factor in the pancreas.
Kaneto H, Matsuoka TA, Miyatsuka T, Kawamori D, Katakami N, Yamasaki Y, Matsuhisa M. Kaneto H, et al. Among authors: matsuhisa m. Front Biosci. 2008 May 1;13:6406-20. doi: 10.2741/3162. Front Biosci. 2008. PMID: 18508668 Review.
286 results